Wednesday 03 July 2024
Internal Reference Number: FOI_7895
Date Request Received: 17/04/2024 00:00:00
Date Request Replied To: 26/04/2024 00:00:00
This response was sent via: By Email
Request Summary: acute myeloid leukaemia (AML)
Request Category: Companies
| Question Number 1: Please see below a Freedom of Information request made by OPEN Health. Please answer the questions with regards to NHS patients, i.e., excluding patients that received treatment as part of clinical trials or private healthcare. 1. Do you treat patients with acute myeloid leukaemia (AML) in your Trust? Answer: If yes, please proceed to Question 3, if no, please answer Question 2 | |
| Answer To Question 1: Yes | |
| Question Number 2: 2. Where do patients diagnosed with AML in your Trust receive treatment? | |
| Answer To Question 2: Patients receive treatment on either Pembroke Ward, Pembroke Suite or the mobile chemotherapy unit. | |
| Question Number 3: Please see attached | |
| Answer To Question 3: Please see attached file with responses To accompany this answer to question 3 please also see the documents listed below:  FOI_7895 - Q3 Completed.pdf | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
